BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 32245974)

  • 1. Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension.
    Reyes-Palomares A; Gu M; Grubert F; Berest I; Sa S; Kasowski M; Arnold C; Shuai M; Srivas R; Miao S; Li D; Snyder MP; Rabinovitch M; Zaugg JB
    Nat Commun; 2020 Apr; 11(1):1673. PubMed ID: 32245974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension.
    Wang C; Xing Y; Zhang J; He M; Dong J; Chen S; Wu H; Huang HY; Chou CH; Bai L; He F; She J; Su A; Wang Y; Thistlethwaite PA; Huang HD; Yuan JX; Yuan ZY; Shyy JY
    Circ Res; 2022 Oct; 131(10):828-841. PubMed ID: 36252121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension.
    Chelladurai P; Kuenne C; Bourgeois A; Günther S; Valasarajan C; Cherian AV; Rottier RJ; Romanet C; Weigert A; Boucherat O; Eichstaedt CA; Ruppert C; Guenther A; Braun T; Looso M; Savai R; Seeger W; Bauer UM; Bonnet S; Pullamsetti SS
    Sci Transl Med; 2022 Jun; 14(648):eabe5407. PubMed ID: 35675437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix stiffening induces a pathogenic QKI-miR-7-SRSF1 signaling axis in pulmonary arterial endothelial cells.
    Woodcock CC; Hafeez N; Handen A; Tang Y; Harvey LD; Estephan LE; Speyer G; Kim S; Bertero T; Chan SY
    Am J Physiol Lung Cell Mol Physiol; 2021 May; 320(5):L726-L738. PubMed ID: 33565360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the epigenetic landscape of pulmonary arterial hypertension: implications for personalized medicine development.
    Dave J; Jagana V; Janostiak R; Bisserier M
    J Transl Med; 2023 Jul; 21(1):477. PubMed ID: 37461108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-cell transcriptomic profile of human pulmonary artery endothelial cells in health and pulmonary arterial hypertension.
    Asosingh K; Comhair S; Mavrakis L; Xu W; Horton D; Taylor I; Tkachenko S; Hu B; Erzurum S
    Sci Rep; 2021 Jul; 11(1):14714. PubMed ID: 34282213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In Pulmonary Arterial Hypertension, Reduced BMPR2 Promotes Endothelial-to-Mesenchymal Transition via HMGA1 and Its Target Slug.
    Hopper RK; Moonen JR; Diebold I; Cao A; Rhodes CJ; Tojais NF; Hennigs JK; Gu M; Wang L; Rabinovitch M
    Circulation; 2016 May; 133(18):1783-94. PubMed ID: 27045138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic potential of KLF2-induced exosomal microRNAs in pulmonary hypertension.
    Sindi HA; Russomanno G; Satta S; Abdul-Salam VB; Jo KB; Qazi-Chaudhry B; Ainscough AJ; Szulcek R; Jan Bogaard H; Morgan CC; Pullamsetti SS; Alzaydi MM; Rhodes CJ; Piva R; Eichstaedt CA; Grünig E; Wilkins MR; Wojciak-Stothard B
    Nat Commun; 2020 Mar; 11(1):1185. PubMed ID: 32132543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-126 affects cell apoptosis, proliferation, cell cycle and modulates VEGF/TGF-β levels in pulmonary artery endothelial cells.
    Yuan Y; Shen C; Zhao SL; Hu YJ; Song Y; Zhong QJ
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):3058-3069. PubMed ID: 31002170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.
    Good RB; Gilbane AJ; Trinder SL; Denton CP; Coghlan G; Abraham DJ; Holmes AM
    Am J Pathol; 2015 Jul; 185(7):1850-8. PubMed ID: 25956031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of hydrogen sulfide on monocrotaline‑induced pulmonary arterial hypertension via inhibition of the endothelial mesenchymal transition.
    Zhang H; Lin Y; Ma Y; Zhang J; Wang C; Zhang H
    Int J Mol Med; 2019 Dec; 44(6):2091-2102. PubMed ID: 31573044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Extracellular Vesicles in Pulmonary Arterial Hypertension: Modulation of Pulmonary Endothelial Function and Angiogenesis.
    Khandagale A; Åberg M; Wikström G; Bergström Lind S; Shevchenko G; Björklund E; Siegbahn A; Christersson C
    Arterioscler Thromb Vasc Biol; 2020 Sep; 40(9):2293-2309. PubMed ID: 32757648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension.
    Hudson J; Farkas L
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34829978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathobiology of pulmonary artery hypertension: role of long non-coding RNAs.
    Zahid KR; Raza U; Chen J; Raj UJ; Gou D
    Cardiovasc Res; 2020 Oct; 116(12):1937-1947. PubMed ID: 32109276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restoration of impaired endothelial myocyte enhancer factor 2 function rescues pulmonary arterial hypertension.
    Kim J; Hwangbo C; Hu X; Kang Y; Papangeli I; Mehrotra D; Park H; Ju H; McLean DL; Comhair SA; Erzurum SC; Chun HJ
    Circulation; 2015 Jan; 131(2):190-9. PubMed ID: 25336633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autophagy contributes to BMP type 2 receptor degradation and development of pulmonary arterial hypertension.
    Gomez-Puerto MC; van Zuijen I; Huang CJ; Szulcek R; Pan X; van Dinther MA; Kurakula K; Wiesmeijer CC; Goumans MJ; Bogaard HJ; Morrell NW; Rana AA; Ten Dijke P
    J Pathol; 2019 Nov; 249(3):356-367. PubMed ID: 31257577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nestin represents a potential marker of pulmonary vascular remodeling in pulmonary arterial hypertension associated with congenital heart disease.
    Zhou JJ; Li H; Qian YL; Quan RL; Chen XX; Li L; Li Y; Wang PH; Meng XM; Jing XL; He JG
    J Mol Cell Cardiol; 2020 Dec; 149():41-53. PubMed ID: 32950539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stromal cells improve hemodynamic function in pulmonary arterial hypertension: identification of microRNAs implicated in modulating endothelial function.
    Wang P; Zhang C; Li J; Luo L; Zhang S; Dong F; Tang Z; Ni S
    Cytotherapy; 2019 Apr; 21(4):416-427. PubMed ID: 30904330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exacerbated inflammatory signaling underlies aberrant response to BMP9 in pulmonary arterial hypertension lung endothelial cells.
    Szulcek R; Sanchez-Duffhues G; Rol N; Pan X; Tsonaka R; Dickhoff C; Yung LM; Manz XD; Kurakula K; Kiełbasa SM; Mei H; Timens W; Yu PB; Bogaard HJ; Goumans MJ
    Angiogenesis; 2020 Nov; 23(4):699-714. PubMed ID: 32813135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injury-Induced Shedding of Extracellular Vesicles Depletes Endothelial Cells of Cav-1 (Caveolin-1) and Enables TGF-β (Transforming Growth Factor-β)-Dependent Pulmonary Arterial Hypertension.
    Oliveira SDS; Chen J; Castellon M; Mao M; Raj JU; Comhair S; Erzurum S; Silva CLM; Machado RF; Bonini MG; Minshall RD
    Arterioscler Thromb Vasc Biol; 2019 Jun; 39(6):1191-1202. PubMed ID: 30943774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.